An update on peptide drugs for voltage-gated calcium channels.
Recent Pat CNS Drug Discov
; 5(1): 14-22, 2010 Jan.
Article
em En
| MEDLINE
| ID: mdl-19751208
ABSTRACT
Voltage-gated calcium channels are one of the major ion channels distributed in the human central nervous system, and mediate an influx of extracellular Ca(2+) in response to membrane depolarization. Calcium channels are of particular interest in a broad range of cellular functions including cell proliferation and differentiation, gene expression, neurite outgrowth, transmitter and hormone release, and brain plasticity. The dysfunction of calcium channels is related to a variety of clinical disorders such as migraine, hemiplegia, and epilepsy. Therefore, calcium channels have gained great pharmaceutical interest as a privileged target class for the treatment of a wide range of human diseases. This review will examine the known marketed peptide drugs for calcium channels and address the development of some important patented peptide molecules targeting calcium channels.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Peptídeos
/
Canais de Cálcio
/
Ativação do Canal Iônico
Idioma:
En
Ano de publicação:
2010
Tipo de documento:
Article